Irene Ghobrial/bloodcancerstoday.com
Jan 21, 2025, 17:03
Irene Ghobrial: Deeper response predicts better outcomes in high-risk-smoldering-myeloma
Irene Ghobrial, Professor Of Medicine at Dana-Farber Cancer Institute, shared a post on LinkedIn about a recent paper by her and colleagues published in Nature Communications:
“Response matters in high-risk smoldering myeloma. Our study also demonstrates that whole genome sequencing and immune cell sequencing can predict response to therapy.”
Authors: Omar Nadeem, Michelle Aranha, Robert Redd, Romanos Sklavenitis-Pistofidis, Irene Ghobrial et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 25, 2025, 19:16
Apr 25, 2025, 19:06
Apr 25, 2025, 18:59
Apr 25, 2025, 18:48
Apr 25, 2025, 18:44
Apr 25, 2025, 18:29